Imunopatologi Sjogren Syndrome (SS) melalui Salivary Epithelial Cells (SGEC)

Nur Ariska Nugrahani(1*)

(1) FKG Universitas Muhammadiyah Surakarta
(*) Corresponding Author

Abstract

Sjogren's Syndrome is the second most autoimmune disease with average indications including decreased secretory creation from the essential exocrine organs, lacrimal organs, and salivary organs. This review means to look into the component of the immunopathology of Sjogren's disorder through Salivary Gland Epithelial Cells. Sjogren's condition will at first trigger the creation of enormous quantities of resistant cells like CD4+ T cells, CD8+ cells, the number of B cells, macrophages, and dendritic cells that will invade target organs like the salivary and lacrimal organs. The cells of the inborn invulnerable framework related to Sjogren's disorder are dendritic cells, macrophages, and NK cells. Dendritic cells in patients with Sjogren's Syndrome play a part as antigen-introducing cells (APC) in atopic germinal focuses in the salivary organs. Macrophages will be enlisted into the salivary organ tissue towards lymphocytes, bringing about an increment in macrophages and making the salivary organs grow. Salivary organ epithelial cells (SGECs) created in the acini organs and epithelial cells will have a cell polarization measure that is constrained by cell-to-cell connections towards the extracellular grid (ECM) through tight-junction.

Keywords: Immunopathology, Sjogren Syndrome, Salivary Gland

Keywords

Oral Pathology ; Oral Medicine

Full Text:

PDF

References

Brandt JE, Priori R, Valesini G and Fairweather D. Sex differences in Sjogren’s syndrome : a comprehensive review of immune mechanism. Biology od Sex Differences. 2015; 6(19) : 1-13.

Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C. Current state of knowledge on primary sjögren’s syndrome, an autoimmune exocrinopathy. J Clin Med. 2020;9(7):1-63.

Kiripolsky J, McCabe Liam G and Kramer JM. Innate Immunity in Sjogren’s syndrome. Clin Immunol. 2017; 182 : 4-13.

Chivasso C, Sarrand J, Perret J, Delporte C, Soyfoo MS. The involvement of innate and adaptive immunity in the initiation and perpetuation of sjögren’s syndrome. Int J Mol Sci. 2021;22(2):1-21.

Argyropoulou, Valentini E, Ferro F, Leone M.C, Cafaro G, Bartoloni and Baldini. One year in review 2018 : Sjogren’s syndrome. Clin Exp Rheumatol. 2018; 36 : S-14 –S-23.

Nisihara R, Skare TL, Cenci E, Gabardo D, Nass F, Utiyama SRR. Anti-alpha-fodrin antibodies in patients with Sjögren’s syndrome secondary to rheumatoid arthritis. J Bras Patol e Med Lab. 2016;52(3):137-141.

Both T, Dalm V, Hagen M and Daele P. Reviewing primary Sjogren’s syndrome : beyond the dryness – from pathophysiology to diagnosis and treatment. International Journal of Medical Sciences. 2017; 14 (3) : 191-200.

Maślińska M, Mańczak M, Kwiatkowska B, Ramsperger V, Shen L, Suresh L. IgA immunoglobulin isotype of rheumatoid factor in primary Sjögren’s syndrome. Rheumatol Int. 2021;41(3):643-649.

Breedveld A, Van Egmond M. IgA and FcαRI: Pathological roles and therapeutic opportunities. Front Immunol. 2019;10(MAR).

Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. The diagnosis and treatment of Sjögren’s syndrome. Dtsch Arztebl Int. 2017;114(20).

Bodewes ILA, Björk A, Versnel MA, Wahren-Herlenius M. Innate immunity and interferons in the pathogenesis of Sjögren’s syndrome. Rheumatol (United Kingdom). 2021;60(6):2561-2573.

Chen W, Cao H, Lin J, Olsen N, Zheng SG. Biomarkers for Primary Sjögren’s Syndrome. Genomics, Proteomics Bioinforma. 2015;13(4):219-223.

Thompson N, Isenberg DA, Jury EC, Ciurtin C. Exploring BAFF: Its expression, receptors and contribution to the immunopathogenesis of Sjögren’s syndrome. Rheumatol (United Kingdom). 2016;55(9):1548-1555.

DOI: 10.23917/jikg.v5i2.15952

Article Metrics

Abstract view(s): 151 time(s)
PDF: 265 time(s)

Refbacks

  • There are currently no refbacks.